Inventiva (IVA) Interest Coverage Ratio (2019 - 2025)

Inventiva's (IVA) quarterly Interest Coverage Ratio came in at 0.99 in Q2 2025, down 73.86% year-on-year from 3.8 in Q2 2024, and down 73.86% quarter-over-quarter from 3.8 in Q4 2024.

Inventiva (IVA) Interest Coverage Ratio (2019 - 2025) Analysis & Trends

Inventiva's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.99 for Q2 2025.

  • On a quarterly basis, Interest Coverage Ratio fell 73.86% year-over-year to 0.99 in Q2 2025; TTM through Jun 2025 was 1.0, a 96.62% decrease from a year earlier, with the FY2025 full-year figure at 0.65, up 40.75% from the prior year.
  • Interest Coverage Ratio eased to 0.99 in Q2 2025 per IVA's latest filing, from 3.8 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 17.43 in Q4 2022 and bottomed at 0.99 in Q2 2025.
  • The 5-year median for Interest Coverage Ratio is 5.17 (2021), against an average of 6.07.
  • Across the five-year window, Interest Coverage Ratio sank 99.16% in 2021 and slumped 35.74% in 2024, its largest moves.
  • Year by year, Interest Coverage Ratio stood at 6.23 in 2021, then jumped by 179.59% to 17.43 in 2022, then tumbled by 65.82% to 5.96 in 2023, then tumbled by 36.2% to 3.8 in 2024, then slumped by 73.86% to 0.99 in 2025.
  • Per Business Quant, the three latest IVA Interest Coverage Ratio figures stand at 0.99 (Q2 2025), 3.8 (Q4 2024), and 3.8 (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Inventiva 842.48 Mn 842.48 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.99
Dec 31, 2024 3.80
Jun 30, 2024 3.80
Dec 31, 2023 5.96
Jun 30, 2023 5.91
Dec 31, 2022 17.43
Jun 30, 2021 6.23
Mar 31, 2021 4.42
Jun 30, 2020 316.43
Mar 31, 2020 523.46
Dec 31, 2019 721.71